UK Renal Registry 19th Annual Report: Chapter 13 Home Therapies in 2015: National and Centre-specific Analyses
(2017)
Journal Article
Tabinor, M., Casula, A., Wilkie, M., Davies, S., Caskey, F., & Lambie, M. (2017). UK Renal Registry 19th Annual Report: Chapter 13 Home Therapies in 2015: National and Centre-specific Analyses. Nephron Physiology, 137(S1), 297-326. https://doi.org/10.1159/000481376
Outputs (4)
Are Peritoneal Dialysis Center Characteristics a Modifiable Risk Factor to Improve Peritoneal Dialysis Outcomes? (2017)
Journal Article
Lambie, M., & Davies, S. J. (2017). Are Peritoneal Dialysis Center Characteristics a Modifiable Risk Factor to Improve Peritoneal Dialysis Outcomes?. Clinical Journal of the American Society of Nephrology, 12(7), 1032-1034. https://doi.org/10.2215/cjn.05260517
Rationale and design of BISTRO: a randomized controlled trial to determine whether bioimpedance spectroscopy-guided fluid management maintains residual kidney function in incident haemodialysis patients (2017)
Journal Article
Davie, S., Coyle, D., Dasgupta, I., Andronis, L., Farrington, K., Wilkie, M., …Caskey, F. (2017). Rationale and design of BISTRO: a randomized controlled trial to determine whether bioimpedance spectroscopy-guided fluid management maintains residual kidney function in incident haemodialysis patients. BMC Nephrology, 18, Article 138. https://doi.org/10.1186/s12882-017-0554-1BACKGROUND: Preserved residual kidney function (RKF) and normal fluid status are associated with better patient outcomes in incident haemodialysis patients. The objective of this trial is to determine whether using bioimpedance technology in prescrib... Read More about Rationale and design of BISTRO: a randomized controlled trial to determine whether bioimpedance spectroscopy-guided fluid management maintains residual kidney function in incident haemodialysis patients.
Ethical issues in dialysis therapy (2017)
Journal Article
Jha, V., Martin, D. E., Bargman, J. M., Davies, S., Feehally, J., Finkelstein, F., …Levin, A. (2017). Ethical issues in dialysis therapy. The Lancet, 389(10081), 1851-1856. https://doi.org/10.1016/s0140-6736%2816%2932408-4Treatment for end-stage kidney disease is a major economic challenge and a public health concern worldwide. Renal-replacement therapy poses several practical and ethical dilemmas of global relevance for patients, clinicians, and policy makers. These... Read More about Ethical issues in dialysis therapy.